Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma

被引：8

作者：

Wang, Qian ^{[1
]}

Xu, Chunwei ^{[2
,3
,4
]}

Wang, Wenxian ^{[3
]}

Zhang, Yongchang ^{[5
]}

Li, Ziming ^{[6
]}

Song, Zhengbo ^{[3
]}

Wang, Jiandong ^{[7
]}

Yu, Jinpu ^{[8
]}

Liu, Jingjing ^{[9
]}

Zhang, Shirong ^{[10
]}

Cai, Xiuyu

Li, Wen ^{[11
]}

Zhan, Ping ^{[4
]}

Liu, Hongbing ^{[4
]}

Lv, Tangfeng ^{[4
]}

Miao, Liyun ^{[12
]}

Min, Lingfeng ^{[13
]}

Li, Jiancheng ^{[14
,15
]}

Liu, Baogang ^{[16
]}

Yuan, Jingping ^{[17
]}

Jiang, Zhansheng ^{[18
]}

Lin, Gen ^{[15
,19
]}

Chen, Xiaohui ^{[15
,20
]}

Pu, Xingxiang ^{[21
]}

Rao, Chuangzhou ^{[22
]}

Lv, Dongqing ^{[23
]}

Yu, Zongyang

Li, Xiaoyan

Tang, Chuanhao

Zhou, Chengzhi ^{[24
]}

Zhang, Junping ^{[25
]}

Guo, Hui ^{[26
]}

Chu, Qian ^{[27
]}

Meng, Rui ^{[28
]}

Liu, Xuewen ^{[29
]}

Wu, Jingxun ^{[30
]}

Hu, Xiao ^{[31
]}

Zhou, Jin ^{[32
]}

Zhu, Zhengfei ^{[33
]}

Chen, Xiaofeng ^{[34
,35
]}

Pan, Weiwei ^{[36
]}

Pang, Fei ^{[37
]}

Zhang, Wenpan ^{[37
]}

Jian, Qijie ^{[37
]}

Wang, Kai ^{[37
]}

Wang, Liping ^{[38
]}

Zhu, Youcai ^{[39
,40
]}

Yang, Guocai ^{[41
]}

Lin, Xinqing ^{[24
]}

Cai, Jing ^{[42
]}

机构：

[1] Nanjing Univ Chinese Med, Dept Resp Med, Jiangsu Prov Hosp Chinese Med, Nanjing, Peoples R China

[2] Chinese Acad Sci, Inst Canc & Basic Med ICBM, Hangzhou, Peoples R China

[3] Univ Chinese Acad Sci, Dept Chemotherapy, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China

[4] Nanjing Univ, Affiliated Jinling Hosp, Dept Resp Med, Med Sch, Nanjing, Peoples R China

[5] Cent South Univ, Dept Med Oncol, Lung Canc & Gastrointestinal Unit, Hunan Canc Hosp,Affiliated Canc Hosp,Xiangya Sch, Changsha, Peoples R China

[6] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Shanghai Lung Canc Ctr, Shanghai, Peoples R China

[7] Nanjing Univ, Affiliated Jinling Hosp, Dept Pathol, Med Sch, Nanjing, Peoples R China

[8] Tianjin Med Univ, Dept Canc Mol Diagnost Core, Canc Inst & Hosp, Tianjin, Peoples R China

[9] Jilin Canc Hosp, Dept Thorac Canc, Changchun, Peoples R China

[10] Zhejiang Univ, Translat Med Res Ctr, Key Lab Clin Canc Pharmacol & Toxicol Res Zhejian, Affiliated Hangzhou Peoples Hosp 1,Canc Ctr,Sch M, Hangzhou, Peoples R China

[11] Zhejiang Univ, Sch Med, Key Lab Resp Dis Zhejiang Prov, Ctr Canc,Dept Resp & Crit Care Med,Affiliated Hos, Hangzhou, Peoples R China

[12] Nanjing Univ, Affiliated Drum Tower Hosp, Dept Resp Med, Med Sch, Nanjing, Peoples R China

[13] Yangzhou Univ, Dept Resp Med, Clin Med Sch, Subei Peoples Hosp Jiangsu Prov, Yangzhou, Peoples R China

[14] Fujian Med Univ, Canc Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China

[15] Fujian Canc Hosp, Fuzhou, Peoples R China

[16] Harbin Med Univ, Canc Hosp, Dept Oncol, Harbin, Peoples R China

[17] Wuhan Univ, Dept Pathol, Renmin Hosp, Wuhan, Peoples R China

[18] Tianjin Med Univ, Dept Integrat Oncol, Canc Inst & Hosp, Tianjin, Peoples R China

[19] Fujian Med Univ, Canc Hosp, Dept Med Oncol, Fuzhou, Peoples R China

[20] Fujian Med Univ, Canc Hosp, Dept Thorac Surg, Fuzhou, Peoples R China

[21] Cent South Univ, Xiangya Sch Med, Dept Med Oncol, Hunan Canc Hosp,Affiliated Canc Hosp, Changsha, Peoples R China

[22] Univ Chinese Acad Sci, Dept Radiotherapy & Chemotherapy, Hwamei Hosp, Ningbo, Peoples R China

[23] Wenzhou Med Univ, Taizhou Hosp, Dept Pulm Med, Taizhou, Peoples R China

[24] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China

[25] Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Thorac Oncol, Taiyuan, Peoples R China

[26] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Peoples R China

[27] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China

[28] Huazhong Univ Sci & Technol, Canc Ctr, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China

[29] Cent South Univ, Xiangya Hosp 3, Dept Oncol, Changsha, Peoples R China

[30] Xiamen Univ, Affiliated Hosp Med 1, Dept Med Oncol, Xiamen, Peoples R China

[31] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Zhejiang Key Lab Radiat Oncol, Canc Hosp, Hangzhou, Peoples R China

[32] Univ Elect Sci & Technol, Dept Med Oncol, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr,Sch Med, Chengdu, Peoples R China

[33] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China

[34] Jiangsu Prov Hosp, Dept Oncol, Nanjing, Peoples R China

[35] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China

[36] Jiaxing Univ, Coll Med, Dept Cell Biol, Jiaxing, Peoples R China

[37] Shanghai OrigiMed Co Ltd, Dept Med, Shanghai, Peoples R China

[38] Baotou Canc Hosp, Dept Oncol, Baotou, Peoples R China

[39] Jiaxing Univ, Dept Thorac Dis, Zhejiang Rongjun Hosp, Affiliated Hosp 3, Jiaxing, Peoples R China

[40] Jiaxing Univ, Dis Diag & Treatment Ctr, Zhejiang Rongjun Hosp, Affiliated Hosp 3, Jiaxing, Peoples R China

[41] Wenzhou Med Univ, Zhoushan Hosp, Dept Thorac Surg, Wenzhou, Peoples R China

[42] Nanchang Univ, Dept Oncol, Affiliated Hosp 2, Nanchang, Peoples R China

[43] Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Pathol, Taiyuan, Peoples R China

[44] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China

[45] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China

[46] Zhejiang Univ, Sch Med, Huzhou Hosp, Dept Resp Med, Huzhou, Peoples R China

[47] Lishui Municipal Cent Hosp, Deartment Oncol, Lishui, Peoples R China

[48] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 2, Med Coll, Xian, Peoples R China

[49] Second Hosp Jilin Univ, Dept Pathol, Changchun, Peoples R China

[50] Peoples Liberat Army Gen Hosp, Med Ctr 5, Senior Dept Oncol, Beijing, Peoples R China

来源：

THORACIC CANCER | 2023年 / 14卷 / 26期

关键词：

diagnosis; malignant pleural mesothelioma; prognosis; treatment; MODULATED RADIATION-THERAPY; PEMETREXED PLUS CARBOPLATIN; MULTICENTER PHASE-II; OPEN-LABEL; EXTRAPLEURAL PNEUMONECTOMY; HEMITHORACIC RADIATION; 1ST-LINE CHEMOTHERAPY; SURGICAL-MANAGEMENT; DOUBLE-BLIND; LUNG-CANCER;

D O I：

10.1111/1759-7714.15022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. Due to the insidious onset and strong local invasiveness of MPM, most patients are diagnosed in the late stage and early screening and treatment for high-risk populations are crucial. The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient survival. The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) developed a national consensus on the clinical diagnosis and treatment of MPM based on existing clinical research evidence and the opinions of national experts. This consensus aims to promote the homogenization and standardization of MPM diagnosis and treatment in China, covering epidemiology, diagnosis, treatment, and follow-up.

引用

页码：2715 / 2731

页数：17

共 50 条

[21] Malignant Pleural Mesothelioma Incidence, Etiology, Diagnosis, Treatment, and Occupational Health
Neumann, Volker
Loeseke, Stefan
Nowak, Dennis
Herth, Felix J. F.
Tannapfel, Andrea
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2013, 110 (18): : 319 - U21
[22] Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment
Cheng-Jun Ban
Huan-Zhong Shi
Yu-Hui Zhang
中华医学杂志英文版, 2017, 130 (01) : 1 - 3
[23] Overview of treatment related complications in malignant pleural mesothelioma
Murphy, David J.
Gill, Ritu R.
ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (11)
[24] Fast Neutron Radiotherapy in the Treatment of Malignant Pleural Mesothelioma
Patel, Shilpen A.
Kusano, Aaron S.
Anh Truong
Stelzer, Keith J.
Laramore, George E.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (01): : 47 - 50
[25] Perspective on malignant pleural mesothelioma diagnosis and treatment
Wald, Ori
Sugarbaker, David J.
ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (06)
[26] Diagnosis and treatment of herpangina: Chinese expert consensus
Hui Yu
Xing-Wang Li
Quan-Bo Liu
Hui-Ling Deng
Gang Liu
Rong-Meng Jiang
Ji-Kui Deng
Ying-Zi Ye
Jian-Hua Hao
Ying-Hu Chen
Guang-Min Nong
Zhao-Bo Shen
Chang-Shan Liu
Ying-Xue Zou
Jin-Zhun Wu
Xing-Dong Wu
Bi-Quan Chen
Ru-Ping Luo
Ai-Wei Lin
Yan Chen
Xiao-Dong Liu
World Journal of Pediatrics, 2020, 16 : 129 - 134
[27] Diagnosis and treatment of herpangina: Chinese expert consensus
Yu, Hui
Li, Xing-Wang
Liu, Quan-Bo
Deng, Hui-Ling
Liu, Gang
Jiang, Rong-Meng
Deng, Ji-Kui
Ye, Ying-Zi
Hao, Jian-Hua
Chen, Ying-Hu
Nong, Guang-Min
Shen, Zhao-Bo
Liu, Chang-Shan
Zou, Ying-Xue
Wu, Jin-Zhun
Wu, Xing-Dong
Chen, Bi-Quan
Luo, Ru-Ping
Lin, Ai-Wei
Chen, Yan
Liu, Xiao-Dong
WORLD JOURNAL OF PEDIATRICS, 2020, 16 (02) : 129 - 134
[28] The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations
Novello, S.
Pinto, C.
Torri, V.
Porcu, L.
Di Maio, M.
Tiseo, M.
Ceresoli, G.
Magnani, C.
Silvestri, S.
Veltri, A.
Papotti, M.
Rossi, G.
Ricardi, U.
Trodella, L.
Rea, F.
Facciolo, F.
Granieri, A.
Zagonel, V.
Scagliotti, G.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 104 : 9 - 20
[29] Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations
Pinto, Carmine
Novello, Silvia
Torri, Valter
Ardizzoni, Andrea
Betta, Pier Giacomo
Bertazzi, Pier Alberto
Casalini, Gianni Angelo
Fava, Cesare
Fubini, Bice
Magnani, Corrado
Mirabelli, Dario
Papotti, Mauro
Ricardi, Umberto
Rocco, Gaetano
Pastorino, Ugo
Tassi, Gianfranco
Trodella, Lucio
Zompatori, Maurizio
Scagliotti, Giorgio
CANCER TREATMENT REVIEWS, 2013, 39 (04) : 328 - 339
[30] Advances in diagnosis and treatment of malignant pleural mesothelioma
Scagliotti, Giorgio Vittorio
Selvaggi, Giovanni
ONCOLOGY REVIEWS, 2007, 1 (02) : 91 - 102

← 1 2 3 4 5 →